Chemical Computing Group Releases FlexX/FlexSIS Integration Technology
MONTREAL–(BUSINESS WIRE)–Chemical Computing Group Inc. (CCG) announces the general release of the software resulting from its close collaboration with BioSolveIT GmbH surrounding FlexX/FlexSIS one of the world’s fastest high-precision docking engines. The integration technology will be included in the 2007.09 version of CCG’s Molecular Operating Environment (MOE).
Paul Labute, President and CEO of CCG, said that “We have worked closely with BioSolveIT over the past year to combine the strengths of MOE and the strengths of FlexX/FlexSIS. The speed and flexibility of FlexX/FlexSIS is unmatched in the industry and we feel that the combination with MOE’s scoring, refinement, and pharmacophore screening technology will be of great benefit to our customers.” He went on to say that “BioSolveIT has a long history of providing high quality virtual screening technology to the pharmaceutical industry and we are very pleased with the results of our mutual efforts.”
Christan Lemmen, co-founder and CEO of BioSolveIT is looking forward to collaborating further with CCG to maximize the potential of the technology integration: “The integration with MOE is very exciting and we feel strongly that the combination of products will provide our customers with the best virtual screening and analysis platform in the industry.” According to him, “The virtual screening market is highly competitive and challenging. Ultimately the customers will seek to combine the best available technologies. We have specialized in that market for over a decade and we are certain that an open and collaborative spirit between successful software providers is an excellent way to deliver real value to our users.”
Both CEOs stated that they expect their customers will be very pleased with the new technology-link and they agree to continue with what can be seen as a generally growing collaborative trend amongst certain leading software providers. Customers will be the ultimate beneficiaries of this trend.
BioSolveIT GmbH is a globally operating cheminformatics and bioinformatics software company. BioSolveIT provides superior custom software solutions for structure-based design, flexible molecular alignment, database searching, library design, and analysis. Its breakthrough computational technologies help to innovate pharmaceutical research fast and effectively – transforming new ideas into real-world success.
BioSolveIT is headquartered in St. Augustin, Germany. Its web site is www.biosolveit.de. Email inquiries can be sent to info@biosolveit.de.
Chemical Computing Group Inc. is a leading supplier of scientific software for Life Sciences and has been operating since 1994. Chemical Computing Group’s software platform is the Molecular Operating Environment (MOE) that integrates visualization, simulation and methodology development in one package. MOE contains a wide variety of built-in applications in the fields of Cheminformatics, Bioinformatics, Computer-Aided Molecular Design and Molecular Modeling. MOE runs on a wide variety of computers including Windows, Linux, Macintosh and Unix systems both for the desktop and in parallel computing clusters. MOE is used by biologists, medicinal chemists and computational chemists in many pharmaceutical companies, biotechnology companies and universities throughout the world.
Chemical Computing Group is headquartered in Montreal, Canada. Its web site is www.chemcomp.com. Email inquiries can be sent to info@chemcomp.com.
